Digital ischemic necrosis in a patient with systematic lupus erythematosus patient after severe acute respiratory syndrome coronavirus 2 infection: a case report-Reference-Cited by-同舟云学术

Digital ischemic necrosis in a patient with systematic lupus erythematosus patient after severe acute respiratory syndrome coronavirus 2 infection: a case report

Published:2024-06-19 Issue:1 Volume:18 Page:
ISSN:1752-1947
Container-title:Journal of Medical Case Reports
language:en
Short-container-title:J Med Case Reports

Author:

Wen Jia-Hao^ORCID,Zheng Kai,Ren Hua-Liang,Zhang Wang-De,Li Chun-Min

Abstract

Abstract Background Patients with coronavirus disease 2019 have a high incidence of thrombosis that decreases after recovery. When coronavirus disease 2019 is accompanied by diseases prone to thrombosis, risk of post-infection thrombotic events may increase. Case presentation We report a case of digital ischemic gangrene in a 24-year-old Chinese female with systemic lupus erythematosus after recovery from coronavirus disease 2019. The pathogenesis was related to clinical characteristics of systemic lupus erythematosus, hypercoagulability caused by coronavirus disease 2019, and second-hit due to viral infection. Conclusion Patients with autoimmune diseases should remain alert to autoimmune system disorders induced by severe acute respiratory syndrome coronavirus 2 and other viruses. Treatment for these patients should be strictly standardized, and appropriate anticoagulation methods should be selected to prevent thrombosis.

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s13256-024-04567-3.pdf

Reference10 articles.

1. GeorgeGalyfos ASMF. Acute limb ischemia among patients with COVID-19 infection. J Vasc Surg. 2022;1(75):329–42. https://doi.org/10.1016/j.jvs.2021.07.222.

2. Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird WC, Bauer KA, Zwicker JI. The long haul COVID-19 arterial thrombosis. Thromb Res. 2020;217:73–5. https://doi.org/10.1016/j.thromres.2022.07.008.

3. Marianthi Kiriakidou CLC. Systemic lupus erythematosus. Ann Intern Med. 2020;11(172):C81–96. https://doi.org/10.7326/AITC202006020.

4. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthrit Care Res. 2009;61(1):29–36. https://doi.org/10.1002/art.24232.

5. Ulanowska M, Olas B. Modulation of hemostasis in COVID-19; blood platelets may be important pieces in the COVID-19 puzzle. Pathogens. 2021;10(3):370. https://doi.org/10.3390/pathogens10030370.